ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,064Medicare Part D Prescriptions Filled, Including Refills

Rank: 301 out of 2429

$587K Total Retail Price of All Prescriptions

Rank: 190 out of 2429

203 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 203 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 5,563 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 483 370 1 1
LISINOPRIL 334 234 2 2
METOPROLOL TARTRATE 251 199 3 9
FUROSEMIDE 211 178 4 5
METFORMIN HCL 197 104 5 8
FAMOTIDINE 188 120 6 42
HEPARIN SODIUM 179 158 7 116
AMLODIPINE BESYLATE 168 159 8 4
WARFARIN SODIUM 157 103 9 11
BENZTROPINE MESYLATE 143 40 R 10 110
LEVOTHYROXINE SODIUM 126 66 11 3
NOVOLOG 115 77 12 127
HYDROCHLOROTHIAZIDE 115 36 12 10
IBUPROFEN 115 57 12 57
OLANZAPINE 112 56 15 101
CLONIDINE HCL 111 39 16 68
RISPERIDONE 109 58 17 52
GABAPENTIN 106 82 18 18
NIFEDIPINE ER 102 49 19 76
DONEPEZIL HCL 95 81 20 26
ALBUTEROL SULFATE 90 47 21 129
PHENYTOIN SODIUM EXTENDED 88 43 22 108
IPRATROPIUM BROMIDE 86 45 23 191
OMEPRAZOLE 86 61 23 7
FLUPHENAZINE HCL 86 19 23 321
DIVALPROEX SODIUM 82 0 26 78
NAMENDA 82 71 26 35
KLOR-CON M20 82 55 26 60
TRAZODONE HCL 80 28 29 50
CLOZAPINE 77 47 30 147
PANTOPRAZOLE SODIUM 77 59 30 34
ENALAPRIL MALEATE 75 52 32 32
HYDROCODONE-ACETAMINOPHEN 74 11 S3 33 6
DIOVAN 73 40 34 36
HALOPERIDOL 72 15 35 146
RANITIDINE HCL 71 40 36 24
CLOPIDOGREL 71 57 36 31
TRAVATAN Z 70 60 38 206
CARVEDILOL 70 46 38 21
GLIPIZIDE 68 54 40 47
LANTUS 67 55 41 45
METOPROLOL SUCCINATE 65 31 42 12
MIRTAZAPINE 62 57 43 63
HYDRALAZINE HCL 61 58 44 81
FRAGMIN 61 51 44 362
HUMALOG 57 25 46 140
SERTRALINE HCL 57 24 46 23
NIASPAN 56 14 48 113
LEVEMIR 55 47 49 193
DIGOXIN 54 49 50 43
SODIUM CHLORIDE 53 38 51 176
POTASSIUM CHLORIDE 52 35 52 14
LEVETIRACETAM 51 31 53 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.